ReviewFrontiers in pharmacology2023

Pharmacologic inhibition of somatostatin receptor 2 to restore glucagon counterregulation in diabetes.

Emily G Hoffman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.